{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Princeton",
      "state": "NJ",
      "country": "United States",
      "classification": "Class III",
      "openfda": {
        "application_number": [
          "ANDA077130"
        ],
        "brand_name": [
          "RIVASTIGMINE TARTRATE"
        ],
        "generic_name": [
          "RIVASTIGMINE TARTRATE"
        ],
        "manufacturer_name": [
          "Dr. Reddy's Laboratories Limited"
        ],
        "product_ndc": [
          "55111-352",
          "55111-353",
          "55111-354",
          "55111-355"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "RIVASTIGMINE TARTRATE"
        ],
        "rxcui": [
          "312835",
          "312836",
          "314214",
          "314215"
        ],
        "spl_id": [
          "b6b13871-d413-7582-bd37-090b800d61f0"
        ],
        "spl_set_id": [
          "0e20124c-725a-0145-996c-2ff908703162"
        ],
        "package_ndc": [
          "55111-352-30",
          "55111-352-60",
          "55111-352-01",
          "55111-352-05",
          "55111-353-30",
          "55111-353-60",
          "55111-353-01",
          "55111-353-05",
          "55111-354-30",
          "55111-354-60",
          "55111-354-01",
          "55111-354-05",
          "55111-355-30",
          "55111-355-60",
          "55111-355-01",
          "55111-355-05"
        ],
        "is_original_packager": [
          true
        ],
        "unii": [
          "9IY2357JPE"
        ]
      },
      "product_type": "Drugs",
      "event_id": "76699",
      "recalling_firm": "Dr. Reddy's Laboratories, Inc.",
      "address_1": "107 College Rd E",
      "address_2": "N/A",
      "postal_code": "08540-6623",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "U.S. nationwide",
      "recall_number": "D-0649-2017",
      "product_description": "RIVASTIGMINE Tartrate Capsules, USP, 1.5 mg, 60-count bottle, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Bachupally 500-900 India, NDC 55111-352-60",
      "product_quantity": "1,728 bottles",
      "reason_for_recall": "Cross-contamination with other products -Related Substances test for Rivastigmine Tartrate Capsules USP, 1.5 mg showed a peak for Ranitidine.",
      "recall_initiation_date": "20170306",
      "center_classification_date": "20170406",
      "termination_date": "20171221",
      "report_date": "20170412",
      "code_info": "Lot #C607323, Exp 10/18"
    }
  ]
}